ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2022

Aug 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2022-08-12

Reporting Person: Wilson Martin (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-12	Stock Option (Right to Buy)	$17.47	A	20318	Acquired	2032-08-11	Common Stock (20318)	Direct
2022-08-12	Restricted Stock Units	$	A	28763	Acquired		Common Stock (28763)	Direct

Footnotes

F1: This option represents a right to purchase a total of 20,318 shares of the Issuer's common stock, which will become fully vested and exercisable on August 12, 2025.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3: The restricted stock units will become fully vested on August 12, 2025.